A citation-based method for searching scientific literature

Françoise Descotes, Norelyakin Kara, Myriam Decaussin-Petrucci, Eric Piaton, Florence Geiguer, Claire Rodriguez-Lafrasse, Jean E Terrier, Jonathan Lopez, Alain Ruffion. Br J Cancer 2017
Times Cited: 39







List of co-cited articles
393 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
Yves Allory, Willemien Beukers, Ana Sagrera, Marta Flández, Miriam Marqués, Mirari Márquez, Kirstin A van der Keur, Lars Dyrskjot, Irene Lurkin, Marcel Vermeij,[...]. Eur Urol 2014
156
53

TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine.
Isaac Kinde, Enrico Munari, Sheila F Faraj, Ralph H Hruban, Mark Schoenberg, Trinity Bivalacqua, Mohamad Allaf, Simeon Springer, Yuxuan Wang, Luis A Diaz,[...]. Cancer Res 2013
164
46

Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
512
33


TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
P Sivaramakrishna Rachakonda, Ismail Hosen, Petra J de Verdier, Mahdi Fallah, Barbara Heidenreich, Charlotta Ryk, N Peter Wiklund, Gunnar Steineck, Dirk Schadendorf, Kari Hemminki,[...]. Proc Natl Acad Sci U S A 2013
209
33

Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA.
Fiona S Togneri, Douglas G Ward, Joseph M Foster, Adam J Devall, Paula Wojtowicz, Sofia Alyas, Fabiana Ramos Vasques, Assa Oumie, Nicholas D James, K K Cheng,[...]. Eur J Hum Genet 2016
70
28

Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer.
Douglas G Ward, Laura Baxter, Naheema S Gordon, Sascha Ott, Richard S Savage, Andrew D Beggs, Jonathan D James, Jennifer Lickiss, Shaun Green, Yvonne Wallis,[...]. PLoS One 2016
45
25

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
25

Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.
Sumit Borah, Linghe Xi, Arthur J Zaug, Natasha M Powell, Garrett M Dancik, Scott B Cohen, James C Costello, Dan Theodorescu, Thomas R Cech. Science 2015
190
25

Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer.
Ismail Hosen, P Sivaramakrishna Rachakonda, Barbara Heidenreich, Petra J de Verdier, Charlotta Ryk, Gunnar Steineck, Kari Hemminki, Rajiv Kumar. Int J Cancer 2015
56
25

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
25

Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.
Simeon U Springer, Chung-Hsin Chen, Maria Del Carmen Rodriguez Pena, Lu Li, Christopher Douville, Yuxuan Wang, Joshua David Cohen, Diana Taheri, Natalie Silliman, Joy Schaefer,[...]. Elife 2018
66
25


Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T Mutation.
Ilaria J Russo, Yongwon Ju, Naheema S Gordon, Maurice P Zeegers, K K Cheng, Nicholas D James, Richard T Bryan, Douglas G Ward. Bladder Cancer 2018
22
40

Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy.
Kim E M van Kessel, Willemien Beukers, Irene Lurkin, Angelique Ziel-van der Made, Kirstin A van der Keur, Joost L Boormans, Lars Dyrskjøt, Mirari Márquez, Torben F Ørntoft, Francisco X Real,[...]. J Urol 2017
60
20

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
848
20


Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
357
17

Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer.
Karin Birkenkamp-Demtröder, Iver Nordentoft, Emil Christensen, Søren Høyer, Thomas Reinert, Søren Vang, Michael Borre, Mads Agerbæk, Jørgen Bjerggaard Jensen, Torben F Ørntoft,[...]. Eur Urol 2016
115
17

Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up.
Rossana Critelli, Francesca Fasanelli, Marco Oderda, Silvia Polidoro, Manuela Bianca Assumma, Clara Viberti, Mirko Preto, Paolo Gontero, Giuseppina Cucchiarale, Irene Lurkin,[...]. Oncotarget 2016
29
24

Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA.
Jonathan C Dudley, Joseph Schroers-Martin, Daniel V Lazzareschi, William Y Shi, Simon B Chen, Mohammad S Esfahani, Dharati Trivedi, Jacob J Chabon, Aadel A Chaudhuri, Henning Stehr,[...]. Cancer Discov 2019
54
17

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.
Iñigo Landa, Ian Ganly, Timothy A Chan, Norisato Mitsutake, Michiko Matsuse, Tihana Ibrahimpasic, Ronald A Ghossein, James A Fagin. J Clin Endocrinol Metab 2013
254
15

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.
Eugene J Pietzak, Aditya Bagrodia, Eugene K Cha, Esther N Drill, Gopa Iyer, Sumit Isharwal, Irina Ostrovnaya, Priscilla Baez, Qiang Li, Michael F Berger,[...]. Eur Urol 2017
136
15

Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer.
Emil Christensen, Karin Birkenkamp-Demtröder, Iver Nordentoft, Søren Høyer, Kirstin van der Keur, Kim van Kessel, Ellen Zwarthoff, Mads Agerbæk, Torben Falck Ørntoft, Jørgen Bjerggaard Jensen,[...]. Eur Urol 2017
90
15

High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder.
Morgan Cowan, Simeon Springer, Doreen Nguyen, Diana Taheri, Gunes Guner, Maria Angelica Mendoza Rodriguez, Yuxuan Wang, Isaac Kinde, Christopher J VandenBussche, Matthew T Olson,[...]. Mod Pathol 2016
23
26

High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins.
Xiaoyong Zheng, Jian Zhuge, Stephania M Bezerra, Sheila F Faraj, Enrico Munari, John T Fallon, Ximing J Yang, Pedram Argani, George J Netto, Minghao Zhong. J Hematol Oncol 2014
44
15

Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
Boaz Kurtis, Jian Zhuge, Caroline Ojaimi, Fei Ye, Dongming Cai, David Zhang, John T Fallon, Minghao Zhong. Ann Diagn Pathol 2016
22
27

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors.
C Billerey, D Chopin, M H Aubriot-Lorton, D Ricol, S Gil Diez de Medina, B Van Rhijn, M P Bralet, M A Lefrere-Belda, J B Lahaye, C C Abbou,[...]. Am J Pathol 2001
344
15

Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma.
Yujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, Makoto Matsushita, Norihiko Kawamura, Yoko Koh, Kosuke Nakano, Cong Wang, Yu Ishizuya, Yoshiyuki Yamamoto,[...]. Cancer Sci 2019
27
22

Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer.
Faysal A Yafi, Fadi Brimo, Jordan Steinberg, Armen G Aprikian, Simon Tanguay, Wassim Kassouf. Urol Oncol 2015
106
15

Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer.
Ricardo Leão, Donghyun Lee, Arnaldo Figueiredo, Thomas Hermanns, Peter Wild, Martin Komosa, Irene Lau, Mathew Mistry, Nuno Miguel Nunes, Aryeh J Price,[...]. Int J Cancer 2019
21
28

Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer.
Patrice Hodonou Avogbe, Arnaud Manel, Emmanuel Vian, Geoffroy Durand, Nathalie Forey, Catherine Voegele, Maria Zvereva, Md Ismail Hosen, Sonia Meziani, Berengere De Tilly,[...]. EBioMedicine 2019
18
33

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
379
12

Prognostic Value of TERT Alterations, Mutational and Copy Number Alterations Burden in Urothelial Carcinoma.
Sumit Isharwal, François Audenet, Esther Drill, Eugene J Pietzak, Gopa Iyer, Irina Ostrovnaya, Eugene Cha, Timothy Donahue, Maria Arcila, Gowtham Jayakumaran,[...]. Eur Urol Focus 2019
16
31

FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study.
Willemien Beukers, Kirstin A van der Keur, Raju Kandimalla, Yvonne Vergouwe, Ewout W Steyerberg, Joost L Boormans, Jorgen B Jensen, José A Lorente, Francisco X Real, Ulrike Segersten,[...]. J Urol 2017
40
12

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.
A Gordon Robertson, Jaegil Kim, Hikmat Al-Ahmadie, Joaquim Bellmunt, Guangwu Guo, Andrew D Cherniack, Toshinori Hinoue, Peter W Laird, Katherine A Hoadley, Rehan Akbani,[...]. Cell 2017
768
12

TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas.
Kun Wang, Tiantian Liu, Li Liu, Jikai Liu, Cheng Liu, Chang Wang, Nan Ge, Hongbo Ren, Keqiang Yan, Sanyuan Hu,[...]. Oncotarget 2014
49
12

Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study.
Song Wu, Peide Huang, Chong Li, Yi Huang, Xianxin Li, Yongqiang Wang, Chao Chen, Zhaojie Lv, Aifa Tang, Xiaojuan Sun,[...]. Eur Urol 2014
65
12

Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder.
Morgan L Cowan, Simeon Springer, Doreen Nguyen, Diana Taheri, Gunes Guner, Maria Angelica Mendoza Rodriguez, Yuxuan Wang, Isaac Kinde, Maria Del Carmen Rodriguez Pena, Christopher J VandenBussche,[...]. Hum Pathol 2016
22
22

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
12

EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Marko Babjuk, Andreas Böhle, Maximilian Burger, Otakar Capoun, Daniel Cohen, Eva M Compérat, Virginia Hernández, Eero Kaasinen, Joan Palou, Morgan Rouprêt,[...]. Eur Urol 2017
12

The economics of bladder cancer: costs and considerations of caring for this disease.
Robert S Svatek, Brent K Hollenbeck, Sten Holmäng, Richard Lee, Simon P Kim, Arnulf Stenzl, Yair Lotan. Eur Urol 2014
259
12

Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria.
Kim E M van Kessel, Leander Van Neste, Irene Lurkin, Ellen C Zwarthoff, Wim Van Criekinge. J Urol 2016
42
12


Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma.
Yair Lotan, Paul OʼSullivan, Jay D Raman, Sharokh F Shariat, Laimonis Kavalieris, Chris Frampton, Parry Guilford, Carthika Luxmanan, James Suttie, Henry Crist,[...]. Urol Oncol 2017
55
12

Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancer.
Tahlita C M Zuiverloon, Madelon N M van der Aa, Theo H van der Kwast, Ewout W Steyerberg, Hester F Lingsma, Chris H Bangma, Ellen C Zwarthoff. Clin Cancer Res 2010
79
12

Epidemiology and risk factors of urothelial bladder cancer.
Maximilian Burger, James W F Catto, Guido Dalbagni, H Barton Grossman, Harry Herr, Pierre Karakiewicz, Wassim Kassouf, Lambertus A Kiemeney, Carlo La Vecchia, Shahrokh Shariat,[...]. Eur Urol 2013
960
12

The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.
Peter A Humphrey, Holger Moch, Antonio L Cubilla, Thomas M Ulbright, Victor E Reuter. Eur Urol 2016
586
12

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.
Richard J Sylvester, Adrian P M van der Meijden, Willem Oosterlinck, J Alfred Witjes, Christian Bouffioux, Louis Denis, Donald W W Newling, Karlheinz Kurth. Eur Urol 2006
12

A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria.
Paul O'Sullivan, Katrina Sharples, Mark Dalphin, Peter Davidson, Peter Gilling, Lisa Cambridge, Justin Harvey, Tumi Toro, Nardia Giles, Carthika Luxmanan,[...]. J Urol 2012
80
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.